A new type of 3D-printable material that gets along with the body's immune system, pioneered by a University of Virginia ...

Cells have an internal skeleton that maintains their structure and also drives their movement. Known as the cytoskeleton, ...

Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

Alzheimer's disease (AD), the leading cause of dementia, affects nearly 40 million individuals globally, resulting in a ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...

In February 1953, two men walked into a pub in Cambridge and announced they had found "the secret of life". It was not an ...

Nucleome Therapeutics ('Nucleome' or 'the Company'), an immunology company tackling the root causes of disease through a revolutionary new approach to solving human genetics, is delighted that its ...

Priority Research Communication by Professor Yogesh Dwivedi and colleagues at the University of Alabama at Birmingham reports original, peer-reviewed findings demonstrating that long noncoding RNAs ...

-- STK-012 is an <ALPHA>/<BETA> biased IL-2 designed to specifically stimulate antigen activated T cells -- Results from an ongoing Phase 1a/1b to be presented at SITC -- Company will also present new ...

PureWow editors select every item that appears on this page, and some items may be gifted to us. Additionally, PureWow may ...